Oriel Therapeutics Inc.

Oriel Therapeutics is a leading respiratory drug delivery and development company serving the pharmaceutical, biotechnology, and diagnostic industries in the development and commercialization of innovative pre-metered unit and multi-dose dry powder delivery systems for medicines for asthma and COPD.Our roots are steeped in breakthrough aerosolization technology - which enabled the development of innovative dry powder inhalation delivery devices. Oriel licensed its initial patented technology related to the use of powder specific fluidization signals, developed at the University of North Carolina at Chapel Hill by Oriel's founders. Since its inception the company has developed an expanding portfolio of intellectual property which is now central to its DPI (dry powder inhaler) platforms. In addition, using the same fundamental principles of powder fluidization, the company has developed IP covering the precise movement of poorly flowing powders for potential industrial applications.

Contact Details: Post Office Box 14087 Research Triangle Park North Carolina 27709 United States of America Tel: (919) 313-1290 Fax: Email: info@orieltherapeutics.com WWW: www.orieltherapeutics.com/

Loading...

Press Releases on Oriel Therapeutics Inc.:
Reportlinker Adds Pulmonary Drug Delivery Technologies - A Global Market Perspective	18th November, 2009	Reportlinker	NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Pulmonary Drug Delivery Technologies - A Global Market Perspective http:/

Oriel Therapeutics Inc. Patents:
US Patent No.	Title
7520278	Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
7451761	Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances
7428446	Dry powder dose filling systems and related methods
7377277	Blister packages with frames and associated methods of fabricating dry powder drug containment systems
7118010	Apparatus, systems and related methods for dispensing and /or evaluating dry powders
→View more Oriel Therapeutics Inc. patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 439 times since April 2007, the link to the organisation's website has been followed 73 times

Recent Search Terms used to find this page: oriel therapeutics | oriel pharma | Oriel Therapeutics | Oriel Therapeutics Inc. | US Patent 7 520 278 | Oriel Therapeutics Inc. inhalation devices | oriel therapeutics 2009 | oriel therapeutics | oriel theraputics | oriel pharma | .

Search for more companies in Research Triangle Park

Search for more companies in North Carolina

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Oriel Therapeutics Inc.